Lau, Wan Yee

Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos)

Kiriyama, S., Kozaka, K., Takada, T., Strasberg, S. M., Pitt, H. A., Gabata, T., Hata, J., Liau, K., Miura, F., Horiguchi, A., et al. (2018) · Journal of Hepato-Biliary-Pancreatic Sciences

Gallbladder and Bile Duct DisordersSepsis Diagnosis and Treatment

Cited by 761

Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis

Mayumi, T., Okamoto, K., Takada, T., Strasberg, S. M., Solomkin, J. S., Schlossberg, D., Pitt, H. A., Yoshida, M., Gomi, H., Miura, F., et al. (2018) · Journal of Hepato-Biliary-Pancreatic Sciences

Gallbladder and Bile Duct DisordersClinical practice guidelines implementation

Cited by 311

Indications and techniques of biliary drainage for acute cholangitis in updated Tokyo Guidelines 2018

Mukai, S., Itoi, T., Baron, T. H., Takada, T., Strasberg, S. M., Pitt, H. A., Ukai, T., Shikata, S., Teoh, A. Y. B., Kim, M., et al. (2017) · Journal of Hepato-Biliary-Pancreatic Sciences

Gallbladder and Bile Duct DisordersPediatric Hepatobiliary Diseases and Treatments

Cited by 204

Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial

Liu, J., Liu, Q., Li, Y., Li, Q., Su, F., Yao, H., Su, S., Wang, Q., Jin, L., Wang, Y., et al. (2020) · Journal for ImmunoTherapy of Cancer

Cancer Immunotherapy and BiomarkersBreast Cancer Treatment Studies

Cited by 183

Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial

Wang, K., Xiang, Y.-J., Yu, H.-M., Cheng, Y.-Q., Liu, Z.-H., Qin, Y.-Y., Shi, J., Guo, W.-X., Lu, C.-D., Zheng, Y.-X., et al. (2024) · Nature Medicine

Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers

Cited by 142